Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy.
Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy.
复制标题
左乙拉西坦可降低特发性全身性癫痫患者连续脑电图监测期间的棘波密度和持续时间。
DOI:
10.1111/j.0013-9580.2004.39503.x
复制
发表时间:
2004
期刊:
影响因子:
5.6
通讯作者:
Gilliam,FrankG
中科院分区:
文献类型:
--
作者:
Gallagher,MartinJ;Eisenman,LawrenceN;Brown,KellyM;Erbayat-Altay,Ebru;Hecimovic,Hrvoje;Fessler,AJames;Attarian,HrayrP;Gilliam,FrankG
Levetiracetam (LEV) reduces the incidence of seizures (1) and interictal epileptiform complexes (2) in patients with localization-related epilepsy. Here we report quantitative analyses of the effect of LEV on the incidence (spike–wave density, SWD) and duration of interictal spike–wave complexes (SWCs) in 10 patients with idiopathic generalized epilepsy (IGE). These patients underwent continuous video/EEG monitoring as part of their diagnostic evaluation, were determined to have IGE [diagnosed by history, interictal and ictal EEG findings, and normal magnetic resonance imaging (MRI)], and initiated LEV during the study. Because SWC incidence varies with time and sleep state, the long sampling by continuous EEG monitoring allowed statistical analyses of SWD and duration that could not be made with routine EEGs.Entire EEG records were not available for patients 1–3. Their responses to LEV were determined from the detailed video/EEG monitoring report and saved EEG samples. Patients 1 and 3 had frequent SWCs before LEV and no SWCs after LEV. Patient 2 had no response. Complete EEG records were available for patients 4–10. Each SWC was identified visually. The SWD was defined as the number of SWC in each 0.2-h time period divided by 0.2.